Know which accounts are ready to buy.
Built for commercial teams at Life Sciences Tools & Services companies selling into pharma, biotech, and research institutions.
MarlowIQ tracks 970+ biopharma companies and academic institutions, 105+ competitors, and 15000+ active clinical trials monitored — surfacing the commercial signals that matter before your competitors see them.
ADC manufacturing capacity is tightening. Two moves in one week point to a multi-year instrument demand surge.
$4.5B US manufacturing build confirmed. GLP-1 insourcing is the demand story of 2026.
AI-assisted early discovery platform launched. The CRO-to-platform pivot is accelerating.
Scores that tell you what to do next.
mIQ ranks your accounts. mGS rates your competitors. Both updated weekly.
15000+ active clinical trials, synced 3× per week.
CT.gov trial data updates automatically. Phase transitions and breakthrough designations surface in account scores the same week they happen.
Two briefs a week. One AI analyst, always on.
Tuesday and Friday briefs filtered for commercial leaders. Between briefs, Ask Marlow answers anything with full platform context loaded.
From login to insight in minutes
No setup. No data migration. The platform knows your market before you arrive.
Read the brief
Every Tuesday and Friday, MarlowIQ publishes an intelligence brief for Life Sciences commercial leaders. Start here — it takes 5 minutes and gives you the market context you need.
Open your Opportunities
Your account universe ranked by buying propensity — updated weekly. The accounts at the top are showing active pipeline signals right now.
Ask Marlow anything
"Which accounts just hit a Phase 3 milestone?" "Where is a competitor gaining share?" Ask the question that was going to take hours. Sourced answers with full platform context loaded.
Built for Life Sciences commercial leaders.
MarlowIQ is in private preview with a curated set of design partners. Reach out if you'd like a walkthrough.